Oracion, Joycil B.
HRN: 27-21-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2025
CEFUROXIME 500MG (TAB)
07/22/2025
07/28/2025
PO
500mg
BID X 7 Days
Thickly MSAF
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: